Challenges in IBD: The Post-Op IBD Patient: Preventing Pouchitis & Recurrence
|
|
- Emory Roy Newman
- 6 years ago
- Views:
Transcription
1 Challenges in IBD: The Post-Op IBD Patient: Preventing Pouchitis & Recurrence Sharon Dudley-Brown, PHD, FNP-BC, FAAN Assistant Professor Johns Hopkins University Baltimore, MD
2 Disclosures Consultant for: AbbVie Takeda
3 Learning Objectives At the conclusion of this presentation, learners will: 1. Develop an approach to the pro-active assessment of post-operative recurrence of IBD, including Crohn s disease and ulcerative colitis. 2. Incorporate the emerging understanding regarding pathogenesis of post-operative recurrence into treatment algorithms, and the development of an individualized prevention strategy for their patients. 3. Critically appraise the available information about treatment of post-operative recurrence in IBD.
4 Case: Pete 21 y.o. presents for second opinion, after a new diagnosis of ileal Crohn s disease, cm ileal involvement On no meds Non-smoker PMH negative You discuss biologics; surgery
5 2 years later.. He returns- worsening symptoms Diarrhea, wt loss, bleeding Still refusing meds? New fistula off TI Finally agrees to surgery Has an uneventful lap IC resection
6 Indications for Surgery Ulcerative colitis: Medically refractory disease/fulminant disease High grade dysplasia or cancer Hemorrhage/transfusion requirements Perforation Crohn s disease: Obstruction Medically refractory disease Hemorrhage/transfusion requirements High grade dysplasia or cancer Growth delay Fistula/abscess
7 The Significance and Rate of Post- Operative Recurrence in IBD Ulcerative colitis: Medically refractory disease: End ileostomy no recurrence IPAA risks of pouchitis, cuffitis, pre-pouch ileitis, Crohn s disease Crohn s disease: Disease of the colon and terminal ileum: End ileostomy recurrence in small bowel very low Resection and primary anastomosis recurrence at anastomosis high Disease of the proximal small bowel: Resection and primary anastomosis recurrence at anastomosis probably high (not studied well)
8 Assessment of Risk of Post-Operative Recurrence Should Occur Pre-operatively Know your patient Discuss the available options Manage medical therapies Communicate with the surgeons Clarify type, extent and severity of disease Discuss plans for immune suppression Be proactive! Institute prevention strategies Smoking cessation for Crohn s
9 Incidence of First Intestinal Surgery in IBD Crohn s Disease 1 Ulcerative Colitis 2 1-Year Surgery Incidence (95% CI) 5-Year Surgery Incidence (95% CI) 1-Year Surgery Incidence (95% CI) 1-Year Surgery Incidence (95% CI) 5-Year Surgery Incidence (95% CI) 1-Year Surgery Incidence (95% CI) Midpoint Year of Study Before ( ) ( ) 6.45 ( ) 9.39% ( %) 15.14% ( %) 23.4% ( %) Midpoint Year of Study Between ( ) ( ) 4.7 ( ) 5.8% ( %) 9.54% ( %) 13.42% ( %) Midpoint Year of Study After ( ) 2.92 ( ) N/A 1.79% ( %) N/A N/A Meta-regression p-value <.1 < In Crohn s disease, the overall 1-year incidence of surgery is 16.7%, 5-year is 32.27%, and 1-year is 48.28%. P-value of time trend <.1 a significant reduction in 1-year surgery incidence with time. Overall, approximately 1 in 5 patients with ulcerative colitis will require surgery within 1 years of diagnosis. 1. Frolkis A, et al. Gastroenterology 213;145(5): Negron et al. presented at DDW 212.
10 Ulcerative Colitis: Assessment & Prevention of Post-operative Complications
11 Ulcerative Colitis: Ileo-pouch Anal Anastomosis Colectomy Cuff/Anal Transition zone J pouch
12 Complications of the Ileal Pouch Surgical/ Mechanical Inflammatory/ Infectious Functional Dysplasia/ Neoplasia Systemic/ Metabolic - Afferent limb syn. - Efferent limb syn. - Strictures - Leaks - Fistulae - Sinuses - Abscess - Adhesions - Re-operation -Pouchitis -Crohn s dis. -Cuffitis -Small bowel bacterial overgrowth -CMV -C. difficile -Polyps - Irritable pouch syn. - Pelvic floor dysfunction - Poor pouch compliance - Pseudoobstruction - Dysplasia - Cancer - Anemia - Osteoporosis - Vitamin B12 deficiency - Malnutrition - Fertility - Sexuality Shen B, et al. Am J Gastroenterol. 25;1(12):
13 Risk Factors for Pouchitis Extensive UC Backwash ileitis Primary sclerosing cholangitis p-anca NOD2/ IL-1 receptor antagonist polymorphisms Ex-smoker NSAIDs Arthralgias Family history of Crohn s disease Fazio VW et al. Ann Surg August; 222(2): ; Schmidt CM et al. Ann Surg May; 227(5): ; J L Lohmuller et al. Ann Surg. 199 May; 211(5): ; Fleshner P et al. Clin Gastroenterol Hepatol. 27 Aug;5(8):952-8; quiz 887; Achkar JP et al.clin Gastroenterol Hepatol. 25 Jan;3(1):6-6; Shen B et al. Am J Gastroenterol. 25 Jan;1(1):93-11; Le Q et al. Inflamm Bowel Dis. 213; 19(1):3-6.
14 Endoscopy Is the Most Valuable Tool for the Diagnosis of Pouchitis 6 5 P <.1 4 Points Symptom Endoscopy Histology Pouchitis No Pouchitis Shen B, Achkar JP, Lasher BA, et al. Gastroenterology 22;121(2):261-7
15 Management of Pouchitis (endoscopic confirmation is preferred) Modified from Shen B, Clin Gastroenterol Hepatol. 213;11(12):
16 Management of Pouchitis (endoscopic confirmation is preferred) Modified from Shen B, Clin Gastroenterol Hepatol. 213;11(12):
17 Management of Pouchitis (endoscopic confirmation is preferred) Modified from Shen B, Clin Gastroenterol Hepatol. 213;11(12):
18 1. Gionchetti et al. Gastroenterology 2; 19: Mimura et al. Gut 24; 53: Shen et al. Aliment Pharacol Ther 25; 22: VSL#3 and Pouchitis VSL#3 is a mixture of Lactobacilli, Bifidobacteria, and Streptrococci strains Maintenance of remission of pouches with VSL#3 15% relapse vs 1% in placebo group at 9mths 1 15% relapse vs 94% in placebo group 2 Open label study: 6/31 patients remained on VSL after 8 mths, 23 quit due to relapses and 2 due to adverse effects 3
19 Can Pouchitis be Prevented? Frequency of Pouchitis with Probiotic Prophylaxis 1 8 % cases with flare-up % P <.5 4% VSL3 Placebo N = 2 6 grams QD x 12 months N = 2 Gionchetti P et al. Gastroenterol 23 May;124(5):122-9.
20 Complications of the Ileal Pouch Surgical/ Mechanical Inflammatory/ Infectious Functional Dysplasia/ Neoplasia Systemic/ Metabolic - Afferent limb syn. - Efferent limb syn. - Strictures - Leaks - Fistulae - Sinuses - Abscess - Adhesions - Re-operation -Pouchitis -Crohn s dis. -Cuffitis -Small bowel bacterial overgrowth -CMV -C. difficile -Polyps - Irritable pouch syn. - Pelvic floor dysfunction - Poor pouch compliance - Pseudoobstruction - Dysplasia - Cancer - Anemia - Osteoporosis - Vitamin B12 deficiency - Malnutrition - Fertility - Sexuality Shen B, et al. Am J Gastroenterol. 25;1(12):
21 Risk Factors for Crohn s of the Pouch Long duration of pouch Shen et al Clin Gastroenterol Hepatol 26 Smoking Shen et al Clin Gastroenterol Hepatol 26; Shen et al, Am J Gastroenterol 24 Preoperative diagnosis of Indeterminate Colitis Delaney et al, Ann of Surg 22 Female gender in a pediatric population Alexander et al, J Pediatr Surg 23 Expression of ASCA IgA Melmed et al, Dis Colon Rectum 28 Family history of CD Melmed et al, Dis Colon Rectum 28
22 Crohn s Disease
23 The Challenges of Surgery in Crohn s Disease It is still required It is often done when all else has failed - but should be embraced as an effective treatment option earlier Ongoing issues and concerns Issues with peri-operative immune suppression Issues with misinterpretation of failure of medical therapy Distinction between fibrostenosis and true medically refractory disease
24 Cumulative Probability of Surgery in Crohn s Disease 1 8 Patients* (%) Years After Onset Mekhjian HS et al. Gastroenterol. 1979;77(4 pt 2):
25 Recurrence After Surgery in Crohn s Disease 1 N=89 8 Survival without surgery Patients (%) 6 4 Survival without laboratory recurrence Survival without symptoms 2 Survival without endoscopic lesions Years Rutgeerts P et al. Gastroenterol. 199;99(4):
26 Post-op Ileocecectomy is the Perfect Opportunity for Prevention! Health Subclinical Inflammation Symptomatic Inflammation Complications Disability Disease Prevention Prevention of Complications Prevention of Symptomatic Disease Prevention of Relapse
27 Risk Stratification for Recurrence in Post-operative Crohn s disease Smoking Perforating-type of disease Small bowel disease Ileocolonic disease Perianal fistulas Duration of disease Age? Clear margins? Length of resection?type of anastomosis Greenstein AJ et al. Gut. 1988;29(5): Bernell O et al. Ann Surg. 2;231(1): Bernell O et al. Br J Surg. 2;87(12): D'Haens GR et al. Gut. 1995;36(5): Lautenbach E et al. Gastroenterol.1998;115(2): Moskovitz D et al. Int J Colorectal Dis. 1999;14(4-5): Kono T et al. Dis Colon Rectum 211 May;54(5):
28 The Neo-TI: The Rutgeerts Score Note that the neo-terminal ileum is not the anastomosis! Rutgeerts Rutgeerts 1 Rutgeerts 2 Normal ileal mucosa Ulceration without normal intervening mucosa <5 aphthous ulcers >5 aphthous ulcers, normal intervening mucosa Severe ulceration with nodules, cobblestoning, or stricture Rutgeerts 3 Rutgeerts 4
29 Symptoms after Crohn s Surgery are Not Always Inflammatory! Symptom/Cause Treatments Post-operative pain Post-resection diarrhesis (rapid transit due to absence of obstruction and muscular hypertrophy) Bile salts Narcotic bowel Bacterial overgrowth Limited analgesia, regional anesthesia when possible Anti-diarrheals Bile acid sequestrant NO narcotics! antibiotics
30 Fecal Calprotectin Can Predict Postoperative CD Endoscopic Recurrence Prospective study of 136 post-operative CD patients using 318 stool samples (POCER STUDY) Fecal Calprotectin Concentration at 6 Months Compared to Rutgeert s Score Using a cut-off of > 1ug/g, fecal calprotectin identifies which patients require colonoscopy and allows 41% of patients to avoid colonoscopy Wright EK, et al. Gastroenterology. 215 (in press).
31 Recurrence Rates of Crohn s Disease in Randomized Placebo Controlled Trials Vaughn BP and Moss AC. World J Gastroenterol 214; 2(5);
32 Role of Bacteria in Post-op Recurrence in Crohn s Disease Unknown Possibilities Loss of the ileocecal valve exposes the neo-terminal ileum to colonic bacteria Bacteria associated with post-op recurrence may have increased adherence and penetrance Evidence Diversion leads to durable remission Antibiotics studied to prevent recurrence Probiotics? Ahmed T et al. Gut 211;6:
33 Post-operative Endoscopic Recurrence Infliximab vs. Placebo % patients Regueiro M et al. 29 Feb;136(2):441-5.e1; quiz 716. Infliximab (n=11) Infliximab vs placebo p=.6 1/11 11/13 Endoscopic Recurrence Placebo (n=13) Endoscopic Recurrence defined as endoscopic scores of i2, i3, or i4.
34 Two year follow-up of endoscopic recurrence in CD pts treated with Study End Trial Post Trial Post Trial 24 pts in the original 1 yr trial: 13 randomized to placebo and 11 to Group PBO PBO Score 2 4 Tx Score At completion of trial, pts had a colonoscopy and were offered open-label PBO PBO PBO Repeat colonoscopy was performed 1 yr later Data available on n=12 with 1 yr of f/u and colonoscopy after trial, and 2 yrs after surgery PBO 4 No Tx No Tx Regueiro M, et al. Clin Gastroenterol Hepatol. 214;12(9): e1
35 Two year follow-up of endoscopic recurrence in CD pts treated with Study End Trial Post Trial Post Trial 24 pts in the original 1 yr trial: 13 randomized to placebo and 11 to At completion of trial, pts had a colonoscopy and were offered open-label Repeat colonoscopy was performed 1 yr later Data available on n=12 with 1 yr of f/u and colonoscopy after trial, and 2 yrs after surgery Group PBO PBO PBO PBO PBO PBO Score Tx No Tx No Tx Score Regueiro M, et al. Clin Gastroenterol Hepatol. 214;12(9): e1
36 Infliximab vs Placebo for the prevention of active CD after ileocolonic resection (PREVENT Trial) RCT: vs Placebo 297 patients ( n=147; PBO n=15) Primary endpoint: clinical recurrence up to 76 wks.* Clin recurr wk 76 Endosc. recurr wk 14 Endosc. recurr wk 76 PBO P- Value 12.9% 2.% % 25.3% % 6% <.1 Trial stopped at wk 14, because primary endpoint not met. Clinical recurrence= CDAI 7; Point increase, CDAI 2; Rutgeerts i2) Reguiero et al. Presentation: 749. Monday pm Ballroom A - WCC
37 Back to Pete. Refuses post-op You tell him to return to see you 3 months post-op for colonoscopy He calls you in 2 months Fevers, weight loss, diarrhea Colonoscopy- Rutgeerts MRE- active disease in ileum Decides to start
38 An Updated Algorithm for Prevention of Post-Op Recurrence in Crohn s Christensen B, Rubin DT. Medical prophylaxis of recurrent Crohn s disease. Ed Fichera A, Krane M. in press 215.
39 Rutgeerts P. Aliment Pharmacol Ther. 26;24 Suppl 3: Calabrese E et al. J Crohns Colitis. 212 Feb 23. Jensen MD et al. Clin Gastroenterol Hepatol. 211 Feb;9(2): What to do in Follow-up after 6 Months? Clinical follow-up only? Repeat colonoscopy in 6 months or 12 months? Less invasive disease monitoring? Fecal calprotectin MR enterography Ultrasound Capsule endoscopy
40 Summary: The Post-Op IBD Patient: Preventing Pouchitis and Recurrence Embrace surgery as an appropriate treatment option at the right time. Understand your patient s risks for complications or recurrence. Weigh risks and benefits of long-term treatment based on risks of disease recurrence. Employ preventive strategies: Stratify follow-up based on risk- don t wait for symptoms! Perform colonoscopy/pouchoscopy when treatment options will be adjusted because of the findings. In Crohn s disease, treat to prevent- timing does matter! Post-operative prevention in UC is less well-defined, but early intervention and confirmation of inflammation is also essential.
Strategies for changing the course of Crohn s disease
Strategies for changing the course of Crohn s disease Maria T. Abreu, MD University of Miami Miller School of Medicine Miami, Florida Where we are now and where we want to be Diagnosis (usually endoscopy)
More informationIleal Pouch Anal Anastomosis: The Preferred Method of Reconstruction after Proctocolectomy in Children
Ileal Pouch Anal Anastomosis: The Preferred Method of Reconstruction after Proctocolectomy in Children Stephanie Jones, D.O. Surgical Fellow March 21, 2011 Ulcerative Colitis Spectrum of inflammatory bowel
More informationSurgical Management of IBD. Val Jefford Grand Rounds October 14, 2003
Surgical Management of IBD Val Jefford Grand Rounds October 14, 2003 Introduction Important Features Clinical Presentation Evaluation Medical Treatment Surgical Treatment Cases Overview Introduction Two
More informationPouchitis and Cuffitis A bloody mess. Sze-Lin Peng Colorectal Surgeon Counties Manukau District Health Board
Pouchitis and Cuffitis A bloody mess Sze-Lin Peng Colorectal Surgeon Counties Manukau District Health Board Ileal-pouch anal anastomosis https://www.pennmedicine.org/for-health-care-professionals/for-physicians/physician-education-and-resources/clinicalbriefings/2018/february/total-proctocolectomy-with-jpouch-reconstruction-for-ulcerative-colitis
More informationDisclosures. What Do I Do When Anti-TNF Therapy Is Not Working Anymore? Fadi Hamid, M.D. Saint Luke s GI Specialists
What Do I Do When Anti-TNF Therapy Is Not Working Anymore? Fadi Hamid, M.D. Saint Luke s GI Specialists Disclosures No financial relationships to disclose. 1 Learning Objectives Case 24M with ileocolonic
More informationBeyond Anti TNFs: positioning of other biologics for Crohn s disease. Christina Ha, MD Cedars Sinai Inflammatory Bowel Disease Center
Beyond Anti TNFs: positioning of other biologics for Crohn s disease Christina Ha, MD Cedars Sinai Inflammatory Bowel Disease Center Objectives: To define high and low risk patient and disease features
More informationPersonalized Medicine in IBD: Where Are We in 2013
Personalized Medicine in IBD: Where Are We in 2013 David A. Schwartz, MD Director, Inflammatory Bowel Disease Center Associate Professor of Medicine Vanderbilt University Medical Center What is Personalized
More informationCrohn s Disease: Should We Treat Based on Symptoms or Based on Objective Markers of Inflammation?
Crohn s Disease: Should We Treat Based on Symptoms or Based on Objective Markers of Inflammation? Edward V. Loftus, Jr., M.D. Professor of Medicine Division of Gastroenterology and Hepatology Mayo Clinic
More informationInflammatory Bowel Disease: Updates and Controversies CASE #1 CASE #1 8/6/2015. What is the most likely diagnosis?
Inflammatory Bowel Disease: Updates and Controversies Tehttp://192.185.93.102/~paulkeij/wpcontent/uploads/2013/07/collaboration.jpgxt August 7, 2015 Meagan M Costedio, MD; Colorectal Surgery; Cleveland
More informationInflammatory Bowel Disease and Surgery: What You Should Know
Inflammatory Bowel Disease and Surgery: What You Should Know Ask the Experts March 9, 2019 Kristen Blaker, MD Colon and Rectal Surgery MetroHealth Medical Center Disclosures None Outline Who undergoes
More informationPredicting the natural history of IBD. Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium
Predicting the natural history of IBD Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium Patient 1 Patient 2 Age 22 Frequent cramps and diarrhea for 6 months Weight
More informationIBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition
IBD 101 Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Objectives Identify factors involved in the development of inflammatory bowel
More informationMaintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice
Aliment Pharmacol Ther 2005; 22: 721 728. doi: 10.1111/j.1365-2036.2005.02642.x Maintenance therapy with a probiotic in antibiotic-dependent pouchitis: experience in clinical practice B. SHEN*, A. BRZEZINSKI*,
More informationEndoscopy in IBD. F.Hartmann K.Kasper-Kliniken (St.Marienkrankenhaus) Frankfurt/M.
F.Hartmann K.Kasper-Kliniken (St.Marienkrankenhaus) Frankfurt/M. F.Hartmann@em.uni-frankfurt.de Indications for endoscopy Diagnosis Management Surveillance Diagnosis Single most valuable tool: ileocolonoscopy
More informationHow do I choose amongst medicines for inflammatory bowel disease. Maria T. Abreu, MD
How do I choose amongst medicines for inflammatory bowel disease Maria T. Abreu, MD Overview of IBD Pathogenesis Bacterial Products Moderately Acutely Inflamed Chronic Inflammation = IBD Normal Gut Mildly
More informationCrohn s Disease: A New Approach to an Old Problem
Management of Postoperative Crohn s Disease: A New Approach to an Old Problem Miguel Regueiro, M.D. Associate Professor of Medicine Associate Chief for Education Clinical Head and Co-Director, IBD Center
More informationThe Role of Surgery in Inflammatory Bowel Disease. Cory D Barrat, MD Colon and Rectal Surgeon Mercy Health
The Role of Surgery in Inflammatory Bowel Disease Cory D Barrat, MD Colon and Rectal Surgeon Mercy Health THANKS FOR INVITING ME! I have no financial disclosures Outline - Who am I and what do I do? -
More informationChronic Refractory Pouch Dysfunction
Chronic Refractory Pouch Dysfunction Anatomy of Pelvic Pouches Afferent limb (neo-ti) Tip of J J S W Inlet Efferent limb Bo Shen, MD The Ed and Joey Story Endowed Chair Professor of Medicine The Cleveland
More informationCCFA. Crohns Disease vs UC: What is the best treatment for me? November
CCFA Crohns Disease vs UC: What is the best treatment for me? November 8 2009 Ellen J. Scherl,, MD, FACP,AGAF Roberts Inflammatory Bowel Disease Center Weill Medical College Cornell University New York
More informationIBD 101. Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition
IBD 101 Ronen Stein, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Objectives Identify factors involved in the development of inflammatory bowel
More informationSURGICAL MANAGEMENT OF ULCERATIVE COLITIS
SURGICAL MANAGEMENT OF ULCERATIVE COLITIS Cary B. Aarons, MD Associate Professor of Surgery Division of Colon & Rectal Surgery University of Pennsylvania AGENDA Background Diagnosis/Work-up Medical Management
More informationMucosal healing: does it really matter?
Oxford Inflammatory Bowel Disease MasterClass Mucosal healing: does it really matter? Professor Jean-Frédéric Colombel, New York, USA Oxford Inflammatory Bowel Disease MasterClass Mucosal healing: does
More informationSurgery for Inflammatory Bowel Disease
Surgery for Inflammatory Bowel Disease Emily Steinhagen, MD Assistant Professor Department of Surgery, Division of Colorectal Surgery University Hospitals Cleveland Medical Center Common Questions Why
More informationRecent Advances in the Management of Refractory IBD
Recent Advances in the Management of Refractory IBD Raina Shivashankar, M.D. Assistant Professor of Medicine Division of Gastroenterology and Hepatology Thomas Jefferson University Philadelphia, PA Outline
More informationPrevention and Management of Postoperative Crohn s disease
Prevention and Management of Postoperative Crohn s disease Miguel Regueiro, M.D. Associate Professor of Medicine Associate Chief for Education Clinical Head and Co-Director, IBD Center Director, Gastroenterology,
More informationComplementary & Alternative Therapies in IBD
Complementary & Alternative Therapies in IBD Laurie Rosales, APRN-CNP OSU Wexner Medical Center Division of Gastroenterology, Hepatology and Nutrition Complementary & Alternative Probiotics Cannabis Fish
More informationNON INVASIVE MONITORING OF MUCOSAL HEALING IN IBD. THE ROLE OF BOWEL ULTRASOUND. Fabrizio Parente
NON INVASIVE MONITORING OF MUCOSAL HEALING IN IBD. THE ROLE OF BOWEL ULTRASOUND Fabrizio Parente Gastrointestinal Unit, A.Manzoni Hospital, Lecco & L.Sacco School of Medicine,University of Milan - Italy
More informationINFLIXIMAB FOR PREVENTION OF POST-OPERATIVE CROHN S DISEASE RECURRENCE: THE PREVENT TRIAL
INFLIXIMAB FOR PREVENTION OF POST-OPERATIVE CROHN S DISEASE RECURRENCE: THE PREVENT TRIAL A. Hillary Steinhart, MD MSc FRCP(C) Medical Lead, Mount Sinai Hospital IBD Centre Professor of Medicine University
More informationchildren Crohn s disease in MR enterography for GI Complications Microscopy Characterization Primary sclerosing cholangitis Anorectal fistulae
MR enterography for Crohn s disease in children BOAZ KARMAZYN, MD PEDIATRIC RADIOLOGY ASSOCIATE PROFESSOR Characterization Crohn disease Idiopathic chronic transmural IBD Increasing incidence Age 7/100,000
More informationSurgical Therapies for the Treatment of IBD!
Surgical Therapies for the Treatment of IBD! Andrew A Shelton, MD Clinical Professor of Surgery Stanford Hospital and Clinics Section of Colon and Rectal Surgery! Ulcerative Colitis v. Crohn s! 30% of
More informationMy Child Has Inflammatory Bowel Disease : Why? What now? What s next?
My Child Has Inflammatory Bowel Disease : Why? What now? What s next? George M. Zacur, M.D., M.S. Clinical Assistant Professor Department of Pediatrics and Communicable Diseases Division of Gastroenterology
More informationSpectrum of Diverticular Disease. Outline
Spectrum of Disease ACG Postgraduate Course January 24, 2015 Lisa Strate, MD, MPH Associate Professor of Medicine University of Washington, Seattle, WA Outline Traditional theories and updated perspectives
More information5/2/2018 SHOULD DEEP REMISSION BE A TREATMENT GOAL? YES! Disclosures: R. Balfour Sartor, MD
5/2/218 SHOULD DEEP REMISSION BE A TREATMENT GOAL? YES! Disclosures: R. Balfour Sartor, MD Grant support for preclinical studies: Janssen, Gusto Global, Vedanta, Artizan BALFOUR SARTOR, MD DISTINGUISHED
More informationIleoanal Pouch Solves the Problem
Ileoanal Pouch Solves the Problem Bruce D George Department of Surgery John Radcliffe Hospital, Falk Symposium 2-3 May 2008 Ileoanal Pouch Solves the Problem? Sometimes Not always Key Issues in Pouch Surgery
More information11/13/11. Biologics for CD and CUC: The Impact on Surgical Outcomes. Principles of Successful Intestinal Surgery
Biologics for CD and CUC: The Impact on Surgical Outcomes Robert R. Cima, M.D., M.A. Associate Professor of Surgery Division of Colon and Rectal Surgery Overview Antibody based medications (biologics)
More informationULCERATIVE COLITIS. Sean Lynch, MD and Richard Bloomfeld, MD Wake Forest University School of Medicine Winston-Salem, NC
ULCERATIVE COLITIS Sean Lynch, MD and Richard Bloomfeld, MD Wake Forest University School of Medicine Winston-Salem, NC What is Ulcerative Colitis? Ulcerative colitis (UC) is a disease marked by inflammation
More informationPEDIATRIC INFLAMMATORY BOWEL DISEASE
PEDIATRIC INFLAMMATORY BOWEL DISEASE Alexis Rodriguez, MD Pediatric Gastroenterology Advocate Children s Hospital Disclosers Abbott Nutrition - Speaker Inflammatory Bowel Disease Chronic inflammatory disease
More informationDiagnostic and Therapeutic Approaches to Dysplasia in Inflammatory Bowel Diseases
Diagnostic and Therapeutic Approaches to Dysplasia in Inflammatory Bowel Diseases Parakkal Deepak, M.B.B.S., M.S. Assistant Professor of Medicine Division of Gastroenterology John T. Milliken Department
More informationDefinitions. Clinical remission: Resolution of symptoms (stool frequency 3/day, no bleeding and no urgency)
CROHN S DISEASE Definitions Clinical remission: Resolution of symptoms (stool frequency 3/day, no bleeding and no urgency) Recurrence: The reappearance of lesions after surgical resection Endoscopic remission:
More informationHomayoon Akbari, MD, PhD
Recent Advances in IBD Surgery Homayoon M. Akbari, MD, PhD, FRCS(C), FACS Associate Professor of Surgery Virginia Commonwealth University Crohn s disease first described as a surgical condition, with the
More informationSurgical Management of IBD in the Age of Biologics
Surgical Management of IBD in the Age of Biologics Lisa S. Poritz, M.D Associate Professor of Surgery Division of Colon and Rectal Surgery Objectives Discuss surgical management of IBD When to operate
More informationNEW CONCEPTS IN CROHN S DISEASE GLENDON BURRESS, MD PEDIATRIC GASTROENTEROLOGY ROCKFORD, IL
NEW CONCEPTS IN CROHN S DISEASE GLENDON BURRESS, MD PEDIATRIC GASTROENTEROLOGY ROCKFORD, IL CROHN S DISEASE Chronic disease of uncertain etiology Etiology- genetic, environmental, and infectious Transmural
More informationCASE DISCUSSION: The Patient with Dysplasia: Surgery or Active Surveillance? Noa Krugliak Cleveland, MD David T. Rubin, MD
CASE DISCUSSION: The Patient with Dysplasia: Surgery or Active Surveillance? Noa Krugliak Cleveland, MD David T. Rubin, MD Disclosure Statement NKC: No relevant conflicts to disclose. DTR: No relevant
More informationPersonalized Medicine in IBD
Personalized Medicine in IBD Anita Afzali MD, MPH Assistant Professor of Medicine Director, Inflammatory Bowel Diseases Program University of Washington Harborview Medical Center CCFA April 2 nd, 2016
More informationPreventing post-operative recurrence
Oxford Inflammatory Bowel Disease MasterClass Preventing post-operative recurrence Dr Oliver Brain Oxford Disclosures Presented at IEE, Oxford 2013 AbbVie sponsored meeting Talk Outline Risk factors for
More informationLatest Treatment Updates for Ulcerative Colitis: Evolving Treatment Goals
Latest Treatment Updates for Ulcerative Colitis: Evolving Treatment Goals Stephen Hanauer, MD Professor of Medicine Medical Director, Digestive Disease Center Northwestern Medicine Chicago, Illinois Speaker
More informationThe Best of IBD at UEGW (Crohn s)
The Best of IBD at UEGW (Crohn s) Iyad Issa MD Head of Gastroenterology, Rafik Hariri Univ Hosp Adjunct Faculty, School of Medicine, Leb Univ Founding Faculty, School Of Medicine, Leb Am Univ 1 The Best
More informationAzienda Ospedaliera S. Camillo Forlanini. Unità Operativa di Gastroenterologia. Moscow June Cosimo Prantera
/ Azienda Ospedaliera S. Camillo Forlanini Unità Operativa di Gastroenterologia Moscow June 2006 Cosimo Prantera ANTIBIOTICS AND BACTERIAL SPECIES Metronidazole Bacteroides - Clostridia Ciprofloxacin Escherichia
More informationAn Update on the Biologic Treatment for Patients with Inflammatory Bowel Disease. David A. Schwartz, MD
An Update on the Biologic Treatment for Patients with Inflammatory Bowel Disease David A. Schwartz, MD Director, Inflammatory Bowel Disease Center Associate Professor of Medicine Vanderbilt University
More informationInflammatory Bowel Disease When is diarrhea not just diarrhea?
Inflammatory Bowel Disease When is diarrhea not just diarrhea? Jackie Kazik, MA, PA C CME Resources CAPA Annual Conference, 2011 Inflammatory Bowel Disease Objectives Discuss what is known about the pathophysiology
More informationInflammatory Bowel Diseases (IBD) Clinical aspects Nitsan Maharshak M.D., IBD Center, Department of Gastroenterology and Liver Diseases Tel Aviv Soura
Inflammatory Bowel Diseases (IBD) Clinical aspects Nitsan Maharshak M.D., IBD Center, Department of Gastroenterology and Liver Diseases Tel Aviv Sourasky Medical Center Tel Aviv, Israel IBD- clinical features
More informationIndex. Surg Clin N Am 87 (2007) Note: Page numbers of article titles are in boldface type.
Surg Clin N Am 87 (2007) 787 796 Index Note: Page numbers of article titles are in boldface type. A Abscesses in anorectal Crohn s disease, 622 intra-abdominal, in Crohn s disease, 590 591 perirectal,
More informationUnderstanding Inflammatory Bowel Diseases (IBD):
Understanding Inflammatory Bowel Diseases (IBD): What Every Patient Needs to Know William H Holderman, MD Digestive Health Specialists Tacoma, WA Today s Objectives Define IBD, its potential causes and
More informationPositioning Biologics in Ulcerative Colitis
Positioning Biologics in Ulcerative Colitis Bruce E. Sands, MD, MS Acting Chief, Gastrointestinal Unit Massachusetts General Hospital Associate Professor of Medicine Harvard Medical School Sequential Therapies
More informationImplementation of disease and safety predictors during disease management in UC
Implementation of disease and safety predictors during disease management in UC DR ARIELLA SHITRIT DIGESTIVE DISEASES INSTITUTE SHAARE ZEDEK MEDICAL CENTER JERUSALEM Case presentation A 52 year old male
More informationCan We Predict the Natural History of Ulcerative Colitis? Edward V Loftus, Jr, MD Professor of Medicine Mayo Clinic Rochester, Minnesota, USA
Can We Predict the Natural History of Ulcerative Colitis? Edward V Loftus, Jr, MD Professor of Medicine Mayo Clinic Rochester, Minnesota, USA Endpoints Overview Hospitalization Surgery Colorectal cancer
More informationPage 1. Is the Risk This High? Dysplasia in the IBD Patient. Dysplasia in the Non IBD Patient. Increased Risk of CRC in Ulcerative Colitis
Screening for Colorectal Neoplasia in Inflammatory Bowel Disease Francis A. Farraye MD, MSc Clinical Director, Section of Gastroenterology Co-Director, Center for Digestive Disorders Boston Medical Center
More informationSurgery for Ulcerative Colitis 11/14/10. Colectomy for Ulcerative Colitis: What your patient should know. Surgery for Ulcerative Colitis
Colectomy for Ulcerative Colitis: What your patient should know Madhulika G. Varma MD Associate Professor and Chief Section of Colorectal Surgery University of California, San Francisco Surgery for Ulcerative
More informationAngie Perrin Lead Nurse/Clinical Nurse Specialist Oxford Radcliffe Hospitals NHS Trust
Angie Perrin Lead Nurse/Clinical Nurse Specialist Oxford Radcliffe Hospitals NHS Trust Background Late in 20th century saw revolutionary surgical advances within colorectal sphere 1978 Parks & Nicholls
More informationSurgical Approach to Crohn s Colitis Segmental or Total Colectomy? Can We Avoid the Stoma?
17 th Panhellenic IBD Congress Thessaloniki May 2018 Surgical Approach to Crohn s Colitis Segmental or Total Colectomy? Can We Avoid the Stoma? Janindra Warusavitarne Consultant Colorectal Surgeon, St
More informationThe role of Surgery and Stomas in IBD
The role of Surgery and Stomas in IBD When do I need it? Can I avoid it? How do I live with it? Kyle G. Cologne, MD Assistant Professor of Surgery USC Division of Colorectal Surgery Topics Surgical Differences
More informationPatho Basic Chronic Inflammatory Bowel Diseases. Jürg Vosbeck Pathology
Patho Basic Chronic Inflammatory Bowel Diseases Jürg Vosbeck Pathology General Group of chronic relapsing diseases with chronic bloody or watery diarrhea Usually ulcerative colitis (UC) or Crohn s disease
More informationAnne Griffiths MD, FRCPC. SickKids Hospital, University of Toronto. Buenos Aires, August 16, 2014
Management and Medical Therapies for Crohn disease: strategies to enhance mucosal healing Anne Griffiths MD, FRCPC SickKids Hospital, University of Toronto Buenos Aires, August 16, 2014 New onset Crohn
More informationMedical Management of Intestinal Strictures
Medical Management of Intestinal Strictures Subrata Ghosh, FRCP, FRCPE, FRCPC, AGAF, FCAHS Professor of Translational Medicine Director of the Institute of Translational Medicine University of Birmingham,
More informationAli Keshavarzian MD Rush University Medical Center
Treatment: Step Up or Top Down? Ali Keshavarzian MD Rush University Medical Center Questions What medication should IBD be treated with? Can we predict which patients with IBD are high risk? Is starting
More informationCase Report Successful Long-Term Use of Infliximab in Refractory Pouchitis in an Adolescent
Gastroenterology Research and Practice Volume 2010, Article ID 860394, 4 pages doi:10.1155/2010/860394 Case Report Successful Long-Term Use of Infliximab in Refractory Pouchitis in an Adolescent Jessica
More informationPerianal and Fistulizing Crohn s Disease: Tough Management Decisions. Jean-Paul Achkar, M.D. Kenneth Rainin Chair for IBD Research Cleveland Clinic
Perianal and Fistulizing Crohn s Disease: Tough Management Decisions Jean-Paul Achkar, M.D. Kenneth Rainin Chair for IBD Research Cleveland Clinic Talk Overview Background Assessment and Classification
More informationTreating Crohn s and Colitis in the ASC
Treating Crohn s and Colitis in the ASC Kimberly M Persley, MD Texas Digestive Disease consultants TASC Meeting Outline IBD 101 Diagnosis Treatment Burden of Disease Role of ASC Inflammatory Bowel Disease
More informationד"ר דוד ירדני המכון לגסטרואנטרולוגיה ומחלות כבד מרכז רפואי סורוקה
ד"ר דוד ירדני המכון לגסטרואנטרולוגיה ומחלות כבד מרכז רפואי סורוקה Presentaion: S.A is 38 years old. Referred for rectal bleeding investigation. Describes several occasions of bleeding and abdominal pain.
More informationSurgery and Stomas in IBD When do I need it? Can I avoid it? How do I live with it?
Surgery and Stomas in IBD When do I need it? Can I avoid it? How do I live with it? Kyle G. Cologne, MD Assistant Professor of Surgery USC Division of Colorectal Surgery Topics Surgical Differences between
More informationTreatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG
Treatment of Inflammatory Bowel Disease Michael Weiss MD, FACG What is IBD? IBD is an immune-mediated chronic intestinal disorder, characterized by chronic or relapsing inflammation within the GI tract.
More informationRisk Factors for Diseases of Ileal Pouch Anal Anastomosis After Restorative Proctocolectomy for Ulcerative Colitis
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2006;4:81 89 Risk Factors for Diseases of Ileal Pouch Anal Anastomosis After Restorative Proctocolectomy for Ulcerative Colitis BO SHEN,* VICTOR W. FAZIO, FEZA
More informationSurgery in Inflammatory Bowel Disease. Rajesh Gupta MS, MCh Surgical Gastroenterology Division Dept of General Surgery PGIMER, Chandigarh
Surgery in Inflammatory Bowel Disease Rajesh Gupta MS, MCh Surgical Gastroenterology Division Dept of General Surgery PGIMER, Chandigarh 1 Ulcerative colitis (UC) Ulcerative colitis (UC) characterized
More informationPrevention of Postoperative Crohn s disease
The Natural Course of postop CD Prevention of Postoperative Crohn s disease is clinically silent initially Miguel Regueiro, M.D. Professor of Medicine & Translational Research Associate Chief, Education
More informationMedical Therapy for Pediatric IBD: Efficacy and Safety
Medical Therapy for Pediatric IBD: Efficacy and Safety Betsy Maxwell, MD Assistant Professor of Clinical Pediatrics Division of Gastroenterology, Hepatology, and Nutrition Pediatric IBD: Defining Remission
More informationCrohn s Disease. Resident Lecture 1/17/19
Crohn s Disease Resident Lecture 1/17/19 Objectives Features/Classification of Crohn s Disease Medical Treatment Surgical Indications Surgical Considerations 2 Case 25 yo F presents to your office with
More informationWhat do we need for diagnosis of IBD
What do we need for diagnosis of IBD Kaichun Wu Dept. of Gastroenterology, Xijing Hospital Fourth Military Medical University Xi an an,, China In China UC 11.6/10 5,CD 1.4/10 5 Major cause of chronic diarrhea
More informationEfficacy and Safety of Treatment for Pediatric IBD
Efficacy and Safety of Treatment for Pediatric IBD Andrew B. Grossman MD Co-Director, Center for Pediatric Inflammatory Bowel Disease Assistant Professor of Clinical Pediatrics Division of Gastroenterology,
More informationDr David Epstein Vincent Pallotti Hospital and University of Cape Town
Inflammatory Bowel Disease Management in South Africa in 2016 Pharmaceutical Care Management Association Dr David Epstein Vincent Pallotti Hospital and University of Cape Town Inflammatory Bowel Disease
More informationSeptember 12, 2015 Millie D. Long MD, MPH, FACG
Update on Biologic Therapy in 2015 September 12, 2015 Millie D. Long MD, MPH, FACG Assistant Professor of Medicine Inflammatory Bowel Disease Center University of North Carolina-Chapel Hill Outline Crohn
More informationDiagnostics and disease monitoring in IBD: State of the art 2011
Diagnostics and disease monitoring in IBD: State of the art 2011 David T. Rubin, MD Associate Professor of Medicine Co-Director, Inflammatory Bowel Disease Center University of Chicago Medical Center The
More informationImpact of endoscopic monitoring in postoperative Crohn s disease patients already receiving pharmacological prevention of recurrence
1130-0108/2015/107/10/586-590 Revista Española de Enfermedades Digestivas Copyright 2015 Arán Ediciones, S. L. Rev Esp Enferm Dig (Madrid Vol. 107, N.º 10, pp. 586-590, 2015 ORIGINAL PAPERS Impact of endoscopic
More informationEfficacy and Safety of Treatment for Pediatric IBD
Efficacy and Safety of Treatment for Pediatric IBD Andrew B. Grossman MD Co-Director, Center for Pediatric Inflammatory Bowel Disease Associate Professor of Clinical Pediatrics Division of Gastroenterology,
More informationEndpoints for Stopping Treatment in UC
Endpoints for Stopping Treatment in UC Jana G. Hashash, MD Assistant Professor of Medicine Inflammatory Bowel Disease Center Division of Gastroenterology, Hepatology, and Nutrition University of Pittsburgh
More informationUnderstanding clinical aspects of Crohn s disease and ulcerative colitis: Implications for the basic scientist
Understanding clinical aspects of Crohn s disease and ulcerative colitis: Implications for the basic scientist Scott Plevy, MD Associate Professor of Medicine, Microbiology & Immunology UNC School of Medicine
More informationDisclosure of Affiliations. The Way We Hope It Goes. Medicines and Surgery for IBD. None. Cases: Sweet and Not So Sweet
Immunomodulators and Complications of Surgery for Inflammatory Bowel Disease Disclosure of Affiliations None Thomas E. Read, MD, FACS, FASCRS Professor of Surgery Tufts University School of Medicine Senior
More informationMedical Management of Inflammatory Bowel Disease
Medical Management of Inflammatory Bowel Disease John K. Marshall MD MSc FRCPC AGAF Division of Gastroenterology McMaster University John K. Marshall: Conflicts of Interest Speaker: AbbVie, Allergan, Ferring,
More informationINFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic
INFLAMMATORY BOWEL DISEASE Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic WHAT IS INFLAMMATORY BOWEL DISEASE (IBD)? Chronic inflammation of the intestinal tract Two related
More informationGuided by Dr. Michal Amitai Head of Abdominal Imaging Department of Diagnostic Imaging Sheba Medical Center Sackler School of Medicine, Tel Aviv
Guided by Dr. Michal Amitai Head of Abdominal Imaging Department of Diagnostic Imaging Sheba Medical Center Sackler School of Medicine, Tel Aviv University 1 SHARE study My year Collaboration between gastroenterology
More informationJonathan R. Dillman, MD, MSc. Associate Professor Department of Radiology Cincinnati Children s Hospital Medical Center
MR Enterography in Children: Interpretation & Value-Added Jonathan R. Dillman, MD, MSc Associate Professor Department of Radiology Cincinnati Children s Hospital Medical Center Disclosures Crohn s disease
More informationCrohn's disease CAUSES COURSE OF CROHN'S DISEASE TREATMENT. Sulfasalazine
Crohn's disease Crohn's disease is an inflammatory condition of the digestive tract that affects children and adults. Common features of Crohn's disease include mouth sores, diarrhea, abdominal pain, weight
More informationINFLAMMATORY BOWEL DISEASE
National University Faculty of Medicine INFLAMMATORY BOWEL DISEASE Gehan M. Osman, MD. MBBS Pediatrician Jaffar Ibn Auf Specialized Hospital EDUCATIONAL OBJECTIVES Definitions and spectrum of (IBD) Epidemiology
More informationColorectal Surgery. Patient Care. Goals and Objectives
Colorectal Surgery Patient Care 1) Interpret the results of clinical evaluations (history, physical examination) performed on patients with a) Hemorrhoids b) Perianal abscess/fistula c) Anal fissure d)
More informationIBD Understanding Your Medications. Thomas V. Aguirre, MD Santa Barbara GI Consultants
IBD Understanding Your Medications Thomas V. Aguirre, MD Santa Barbara GI Consultants IBD Understanding Your Medications (& Your Doctor) Thomas V. Aguirre, MD Santa Barbara GI Consultants Disclosure I
More informationPosition of Biologics in IBD Circa 2006: Top Down vs. Step Up Therapy
Position of Biologics in IBD Circa 2006: Top Down vs. Step Up Therapy Stephen B. Hanauer, MD University of Chicago Potential Conflicts: Centocor/Schering, Abbott, UCB, Elan, Berlex, PDL Goals of Treatment
More informationCase Presentations #2 Saturday November 13, Case #1 HPI 11/14/10. Uma Mahadevan-Velayos MD. Complicated Crohn s Pregnancy
Case Presentations #2 Saturday November 13, 2010 Uma Mahadevan-Velayos MD Case #1 Complicated Crohn s Pregnancy HPI 34 yo F with Crohn s disease presents to office 18 weeks pregnant, moved back to SF from
More informationIBD Tools to Aid in the Accurate Diagnosis of Inflammatory Bowel Disease
IBD Tools to Aid in the Accurate Diagnosis of Inflammatory Bowel Disease Inflammatory Bowel Disease Experts in Autoimmunity Inova Diagnostics offers a complete array of methods to aid in the diagnosis
More informationMucosal Healing in Crohn s Disease. Geert D Haens MD, PhD University Hospital Gasthuisberg University of Leuven Leuven, Belgium
Mucosal Healing in Crohn s Disease Geert D Haens MD, PhD University Hospital Gasthuisberg University of Leuven Leuven, Belgium Mucosal Lesions in CD: General Features CD can affect the entire GI tract
More informationObjec-ve. Case Presenta-ons and Ques-ons to Panel. Dysplasia case 11/13/11
Case Presenta-ons and Ques-ons to Panel UCSF IBD Symposium November 12, 2011 Moderator Fernando Velayos MD Panelists Brian Feagan, MD James Lewis, MD MSCE Robert Cima, MD Hueylan Chern, MD Sunanda Kane,
More informationInflammatory Bowel Disease
Inflammatory Bowel Disease William Sonnenberg, MD Titusville, PA Disclosure Dr. William Sonnenberg has no conflict of interest, financial agreement, or working affiliation with any group or organization.
More information